相似文献
1
Editorial: Novel and potential markers for prediction of outcome in patients with acute and chronic coronary heart disease.
Front Cardiovasc Med. 2019 May 22;6:66. doi: 10.3389/fcvm.2019.00066. eCollection 2019.
2
Increased alpha-defensin expression is associated with risk of coronary heart disease: a feasible predictive inflammatory biomarker of coronary heart disease in hyperlipidemia patients.
Lipids Health Dis. 2016 Jul 18;15:117. doi: 10.1186/s12944-016-0285-5.
3
Multimarker prediction of coronary heart disease risk: the Women's Health Initiative.
J Am Coll Cardiol. 2010 May 11;55(19):2080-91. doi: 10.1016/j.jacc.2009.12.047.
4
Editorial: Novel and potential biomarkers for prediction of outcome in patients with chronic and acute coronary heart disease, volume II.
Front Cardiovasc Med. 2024 May 28;11:1432580. doi: 10.3389/fcvm.2024.1432580. eCollection 2024.
5
Biomarkers in stable coronary heart disease, their modulation and cardiovascular risk: The LIPID biomarker study.
Int J Cardiol. 2015 Dec 15;201:499-507. doi: 10.1016/j.ijcard.2015.07.080. Epub 2015 Aug 16.
6
Association of high sensitivity C-reactive protein with coronary heart disease prediction, but not with carotid atherosclerosis, in patients with hypertension.
Circ J. 2004 Apr;68(4):297-303. doi: 10.1253/circj.68.297.
7
Association of Coronary Artery Calcification with Estimated Coronary Heart Disease Risk from Prediction Models in a Community-Based Sample of Japanese Men: The Shiga Epidemiological Study of Subclinical Atherosclerosis (SESSA).
J Atheroscler Thromb. 2018 Jun 1;25(6):477-489. doi: 10.5551/jat.42416. Epub 2017 Dec 5.
8
PPBP and DEFA1/DEFA3 genes in hyperlipidaemia as feasible synergistic inflammatory biomarkers for coronary heart disease.
Lipids Health Dis. 2017 Apr 19;16(1):80. doi: 10.1186/s12944-017-0471-0.
9
Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease.
J Am Coll Cardiol. 2017 Aug 15;70(7):813-826. doi: 10.1016/j.jacc.2017.06.030.
10
What is the role of alternative biomarkers for coronary heart disease?
Clin Endocrinol (Oxf). 2011 Sep;75(3):289-93. doi: 10.1111/j.1365-2265.2011.04045.x.
本文引用的文献
1
Anticytokine Agents: Targeting Interleukin Signaling Pathways for the Treatment of Atherothrombosis.
Circ Res. 2019 Feb;124(3):437-450. doi: 10.1161/CIRCRESAHA.118.313129.
2
Aspirin for primary cardiovascular disease prevention: what we know and what we don't know.
Intern Med J. 2019 Jan;49(1):12-14. doi: 10.1111/imj.14190.
3
Association of Multiple Biomarkers With Risk of All-Cause and Cause-Specific Mortality After Acute Coronary Syndromes: A Secondary Analysis of the PLATO Biomarker Study.
JAMA Cardiol. 2018 Dec 1;3(12):1160-1166. doi: 10.1001/jamacardio.2018.3811.
4
Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer.
N Engl J Med. 2019 Jan 3;380(1):23-32. doi: 10.1056/NEJMoa1811403. Epub 2018 Nov 10.
5
Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease.
N Engl J Med. 2019 Jan 3;380(1):33-44. doi: 10.1056/NEJMoa1809944. Epub 2018 Nov 10.
6
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.
N Engl J Med. 2019 Jan 3;380(1):11-22. doi: 10.1056/NEJMoa1812792. Epub 2018 Nov 10.
7
Pathology of Peripheral Artery Disease in Patients With Critical Limb Ischemia.
J Am Coll Cardiol. 2018 Oct 30;72(18):2152-2163. doi: 10.1016/j.jacc.2018.08.002. Epub 2018 Aug 27.
8
Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus.
N Engl J Med. 2018 Oct 18;379(16):1529-1539. doi: 10.1056/NEJMoa1804988. Epub 2018 Aug 26.
9
Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy.
Eur Heart J. 2018 Apr 1;39(13):1078-1085. doi: 10.1093/eurheartj/ehy013.
10
Reducing the Global Burden of Cardiovascular Disease, Part 2: Prevention and Treatment of Cardiovascular Disease.
Circ Res. 2017 Sep 1;121(6):695-710. doi: 10.1161/CIRCRESAHA.117.311849.
Zotero 插件